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        Introduction 
  In the vascular system, mitochondria play an important role, not 
only as the powerhouse of the cell, but also as an im  portant regula-
tor of vascular function (  Moncada and Erusalimsky, 2002  ; 
 Quintero et al., 2006  ;   Madamanchi and Runge, 2007  ). Functional 
mitochondria consume oxygen to form ATP but also produce a 
certain amount of superoxide (O 
2     ) during respiration. Within mi-
tochondria, complex I and III have been shown to be the sites 
of superoxide production (  Boveris et al., 1976  ;   Takeshige and 
Minakami, 1979  ). Under normal physiological conditions, the 
amount of superoxide produced is estimated to be   1% of oxygen 
uptake (  Du et al., 1998  ). O 
2      can be further converted to hydrogen 
peroxide (H  2 O 2  ) or react with nitric oxide (NO) to form per-
oxynitrite (NOO 
     ;   Cai, 2005  ). All these reactive oxygen species 
(ROS) have been proven to act as signaling molecules impacting 
many basic cellular functions such as proliferation and apoptosis. 
For example, H  2 O 2   has been shown to activate various pathways 
in endothelial cells (ECs) and smooth muscle cells (SMCs) 
  including PKC, MAPK, phosphatidyl inositol 3-kinase (PI3-K)/
protein kinase B (Akt), p38 MAPK as well as Ca 
2+   signaling, 
thereby modulating vascular homeostasis (  Yang et al., 1998  ; 
    Connor et al., 2005  ;   Lucchesi et al., 2005  ;   Oeckler et al., 2005  ). 
When mitochondrial function is affected, mitochondrial ROS pro-
duction can be increased and hence infl  uence the described path-
ways to trigger cellular dysfunction (  Gutierrez et al., 2006  ). For 
example, ROS produced from mitochondria has been shown to 
contribute to EC dysfunction and the progression of atheroscle-
rosis (  Madamanchi and Runge, 2007  ). Reducing mitochondrial 
ROS levels by overexpressing thioredoxin in the mitochondria of 
ECs has been shown to improve EC function and reduce athero-
sclerosis (  Zhang et al., 2007  ). Thus, there is compelling evidence 
that mitochondria are essential for vascular homeostasis. 
  A protein that has been shown to be important for maintain-
ing mitochondrial function in lower organisms is prohibitin-1 
(PHB1). PHB1 forms a high molecular complex with PHB2 in 
the inner mitochondrial membrane (  Tatsuta et al., 2005  ;   Ahn 
et al., 2006  ); this complex exerts a chaperonelike function for 
newly synthesized mitochondrial proteins and thereby regulates 
P
rohibitin 1 (PHB1) is a highly conserved protein that 
is mainly localized to the inner mitochondrial mem-
brane and has been implicated in regulating mito-
chondrial function in yeast. Because mitochondria are 
emerging as an important regulator of vascular homeo-
stasis, we examined PHB1 function in endothelial cells. 
PHB1 is highly expressed in the vascular system and 
knockdown of PHB1 in endothelial cells increases mito-
chondrial production of reactive oxygen species via in-
hibition of complex I, which results in cellular senescence. 
As a direct consequence, both Akt and Rac1 are hyper-
activated, leading to cytoskeletal rearrangements and de-
creased endothelial cell motility, e.g., migration and tube 
formation. This is also reﬂ  ected in an in vivo angiogenesis 
assay, where silencing of PHB1 blocks the formation of 
functional blood vessels. Collectively, our results provide 
evidence that PHB1 is important for mitochondrial func-
tion and prevents reactive oxygen species  –  induced senes-
cence and thereby maintains the angiogenic capacity of 
endothelial cells.
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was isolated and sections analyzed by indirect immunofl  uores-
cence for PHB1. As seen in   Fig. 1 A  , PHB1 was found in SMCs 
(  Fig. 1 A  , arrows) as well as ECs (arrowheads) in the vessel wall 
labeled with platelet EC adhesion molecule 1 (PECAM-1), a 
marker protein for ECs (  Fig. 1 B  ). Prohibitins have been identi-
fi  ed in several intracellular locations including mitochondria, 
nuclei, lipid rafts, and the cytoplasm, depending on the cell type 
analyzed (  Ikonen et al., 1995  ;   Wang et al., 2002a  ;   Morrow and 
Parton, 2005  ;   Rastogi et al., 2006b  ). To examine the localization 
of PHB1 in EC, immunofl  uorescence microscopy of PHB1 in 
bovine aortic ECs (BAECs) was performed. A small fraction of 
PHB1 was localized to nuclear regions, however, the main frac-
tion of PHB1 colocalized with the vital mitochondrial marker 
MitoTracker (  Fig. 1 B  ) throughout the cells. PHB1 was also de-
tectable by Western blotting in BAECs and mouse aortic and ca-
rotid arterial lysates ( Fig. 1 C ). PHB1 was also present in a human 
EC line (EA.hy926), human umbilical vein ECs (HUVECs), and 
mouse lung ECs (unpublished data). 
  Knockdown of PHB1 causes a senescence-
like phenotype in ECs 
  Because mitochondrial localized PHB1 is involved in regulating 
mitochondrial function in yeast (  Roskams et al., 1993  ;   Steglich 
et al., 1999 ;  Piper et al., 2002 ) and loss of PHB1 homologues delays 
cellular senescence in yeast, bacteria, and plants (  Roskams et al., 
1993  ;   Piper et al., 2002  ;   Chen et al., 2005  ), we sought to examine 
the function of mitochondrial PHB1 in ECs using an RNAi 
approach to reduce PHB1 protein levels. Transfection of ECs with 
control RNAi had no effect on the levels of PHB1, whereas 
sequence-specifi  c RNAi to PHB1 markedly reduced PHB1 levels 
(  Fig. 2 A  ). Knockdown of PHB1 in ECs changed their mor-
phology to a more fl  at but densely packed morphology that is 
mitochondrial function and biogenesis in yeast (  Steglich et al., 
1999 ).  Additionally,  its  defi  ciency is associated with defective 
mitochondrial biogenesis in   Caenorhabditis elegans   ( Artal-Sanz 
et al., 2003 ), yet the importance of PHB1 in mammalian mitochon-
dria remains elusive. However, PHB1 expression could be linked to 
cellular senescence, a stage of low metabolic turnover caused either 
by telomere shortening or DNA-damaging stress factors such as 
ROS (  Passos and Von Zglinicki, 2006  ). PHB1 is down-regulated in 
aging animal cells as well as human fi  broblasts ( Coates et al., 2001 ) 
and deletion mutants or knockdown of prohibitins in yeast, bacte-
ria, and plants display a senescence-like phenotype (  Roskams 
et al., 1993 ;  Coates et al., 1997 ;  Piper et al., 2002 ;  Chen et al., 2005 ). 
Additionally, the expression of PHB1 is also down-regulated after 
induction of oxidative stress in epithelial cells in vitro as well as in 
diseases linked to enhanced ROS such as ulcerative colitis and 
Crohn ’ s disease ( Theiss et al., 2007 ). Cellular senescence, increased 
ROS, and mitochondrial dysfunction are associated with vascular 
disease ( Minamino and Komuro, 2007 ), however, it is not known if 
PHB1 is able to collectively control these events or have an impact 
on vascular homeostasis. 
  Here, we show that PHB1 is amply expressed in mito-
chondria of ECs and, by regulating mitochondrial integrity, 
ROS production via complex I, and delaying senescence in EC, 
controls signaling pathways that govern diverse functions of the 
endothelium such as cell proliferation, migration, tube forma-
tion, and angiogenesis in vivo. 
  Results 
  PHB1 is expressed in the vascular system 
and localizes to mitochondria 
  Initially, the expression of PHB1 in the vascular system was ex-
amined in vivo and in vitro. The descending aorta of   C57B6   mice 
  Figure 1.       Expression of PHB1 in the vascular system.   
(A) Mouse aortas were parafﬁ  n embedded and sec-
tioned and PHB1 protein expression was analyzed by 
immunoﬂ  uorescence (red) microscopy compared with 
PECAM-1 (as an EC marker, green) with a 20  ×   objec-
tive. Arrows and arrowheads depict PHB1 in SMCs 
and ECs, respectively. Bars, 10     m. (B) Localization of 
PHB1 (green) was analyzed in ECs by indirect immuno-
ﬂ  uorescence compared with MitoTracker (red) and co-
localization is shown (orange; blue, DAPI). Bars, 10    m.
(C) Western blot analysis of PHB1 in lysates from 
BAECs and mouse aorta and carotid arteries.     103 PROHIBITIN CONTROLS SENESCENCE AND ANGIOGENESIS   •   SCHLEICHER ET AL.
characterized by a drop in mitochondrial membrane potential 
and increased ROS production, is often involved in cellular 
senescence. Therefore, we examined if PHB1 was regulating 
these two additional indices of senescence. 
  ROS levels were measured by FACS analysis of control 
and PHB1-depleted ECs upon labeling with CM-H  2 -DCFDA 
(  Fig. 3 A  ). ROS levels were signifi  cantly increased in cells lack-
ing PHB1 (  Fig. 3 A  , red) compared with control (solid gray) and 
could be reversed by preincubation with the H  2 O 2   scavenger 
polyethylene glycol (PEG)  –  catalase (green). This result was 
confi  rmed by measuring H  2 O 2   levels in cell lysates with the 
fl  uorometric probe Amplex red, also showing a signifi  cant accu-
mulation of H  2 O 2  after knockdown of PHB1 (Fig. S1 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200706072/DC1). 
  Because there are several possible sources of ROS in ECs, 
e.g., mitochondria, the NADPH oxidase, xanthine oxidase, and 
endothelial NO synthase, we generated mitochondrial DNA  –
  depleted BAEC, e.g., rho  °   ECs, and measured ROS levels after 
knockdown of PHB1. Immunofl  uorescence analysis of rho  °   ECs 
upon staining with reduced MitoTracker confi  rmed that no 
a characteristic of senescent cells (  Fig. 2 B  ). To examine if the loss 
of PHB1 induces cellular senescence in ECs, we tested for several 
hallmarks for senescence upon knockdown of PHB1. As one func-
tional hallmark of cellular senescence, knockdown of PHB1 re-
sulted in a decrease in cellular proliferation (  Fig. 2 C  ) that was 
caused by an increase in both G1 and sub-G1 populations of the cell 
cycle with slightly enhanced apoptosis (  Table I  ). The loss of PHB1 
also increased the expression of the negative regulators of cell cycle 
progression p16 and p21, which are biochemical markers of cell 
senescence (  Fig. 2 D  ;   Alcorta et al., 1996  ). Finally as a well-
accepted biomarker of cellular senescence, we tested for senes-
cence-associated   -galactosidase expression at pH 6 in ECs ( Dimri 
et al., 1995  ). Although hardly any positive staining was detectable 
under control conditions, the cells depleted of PHB1 showed a sig-
nifi  cant increase in     -galactosidase expression (  Fig. 2, E and F  ). 
  Loss of PHB1 alters mitochondrial function 
  Mitochondrial localized PHB1 is involved in mitochondrial 
function in yeast (  Roskams et al., 1993  ;   Steglich et al., 1999  ; 
  Piper et al., 2002  ) and mitochondrial dysfunction, which is 
  Figure 2.       RNAi-mediated knockdown of PHB1 causes a senescence-like phenotype in ECs.   (A) Western blot analysis of PHB1 and     -actin in EC lysates from 
control and PHB1 knockdown cells. (B) Cell morphology was analyzed by live imaging phase contrast microscopy. Bars, 50     m. (C) Proliferation assays 
were performed after knockdown of PHB1 for the indicated time points and compared with control cells.   n   = 6; *, P   <   0.05. (D) Expression of p21, p16, 
and     -actin in PHB1 knockdown and control HUVECs was determined by Western blotting. (E) BAECs transfected with control or PHB1-speciﬁ  c siRNA were 
stained for     -galactosidase with x-gal at pH 6 and images were taken using a 10  ×   phase contrast objective. Bars, 100   μ  m. (F)     -galactosidase  –  positive 
cells were quantiﬁ  ed by counting positive and negative cells in three random vision ﬁ  elds and averaging the results. Error bars show the calculated standard 
deviation.   n   = 3; *, P   <   0.05.     JCB • VOLUME 180 • NUMBER 1 • 2008  104
tion in the absence and presence of oligomycin, which inhibits 
ATP synthase and is predicted to reduce oxygen consumption in 
effi  ciently coupled mitochondria. Oligomycin inhibited respira-
tion to the same degree in control and PHB-inhibited ECs, which 
suggests that a similar degree of coupling was maintained despite 
the decreased complex I contribution to respiration in response to 
PHB knockdown (Fig. S1 B). Collectively, these results indicate 
that mitochondrial electron transport is partially blocked at com-
plex I and that this is likely the source of ROS production in the 
PHB1-inhibited cells. However, the total mitochondrial oxygen 
consumption was maintained apparently by compensatory mech-
anisms that allow effi  cient electron fl  ow to continue through com-
plexes II and III despite the complex I inhibition. 
  PHB1 regulates Rac1 activity via the 
PI3-K  –  Akt pathway 
  Because ROS are known to participate in signal transduction 
pathways (  Yang et al., 1998  ;   Connor et al., 2005  ;   Lucchesi et al., 
2005  ;   Oeckler et al., 2005  ), we checked for alterations in 
several redox-sensitive pathways upon knockdown of PHB1. 
Compared with ECs treated with control RNAi, knockdown of 
PHB1 increased VEGF-simulated Akt phosphorylation on serine 
473 (S473). The increased phosphorylation of Akt was prevented 
by preincubation of cells with the H  2 O 2   scavenger PEG-catalase 
(  Fig. 4 A  ), which suggests that H  2 O 2   was responsible for Akt 
activation. Furthermore, the addition of exogenous H  2 O 2   to  ECs 
activated Akt phosphorylation on S473 (  Fig. 4 B  ), underlining 
the concept of ROS-dependent Akt activation. 
  Next, we examined pathways downstream of Akt, i.e., eNOS 
and Rac1, in ECs defi  cient in PHB1. A reduction in PHB1 increased 
the phosphorylation of eNOS on its Akt-sensitive site S1179 and 
also promoted NO release from cells (Fig. S2, A and B, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200706072/DC1). 
Another downstream partner of Akt that is involved in cell 
motility and thus could be responsible for the observed change 
in cell morphology (  Fig. 2 B  ) is the small GTPase Rac1 (  Burridge 
and Wennerberg, 2004  ). VEGF-stimulated Rac1 activity was 
clearly elevated in cells lacking PHB1 and Rac1 activity was 
dependent on the PI3-K pathway because preincubation with 
PI3-K inhibitors wortmannin or LY294002 blocked Rac1 acti-
vation (  Fig. 4 C  ). 
respiring mitochondria were present in these cells (  Fig. 3 B  ). Also, 
in these cells, the increase of ROS production upon loss of PHB1 
was eliminated (  Fig. 3 C  ), clearly indicating mitochondrial respira-
tion as the source of elevated ROS levels upon loss of PHB1. 
  Mitochondrial membrane potential (     )  was  assessed 
using the radiometric dye JC-1, which localizes as a red monomer 
at the mitochondrial membrane under normal conditions and 
forms a green dimer when the mitochondrial membrane de-
polarizes. Compared with the control, both indirect immuno-
fl  uorescence (  Fig. 3 D  ) and FACS analysis (  Fig. 3 E  ) revealed a 
drop in red fl  uorescence and an increase in green fl  uorescence 
after knockdown of PHB1, indicating a depolarization of the 
mitochondrial membrane. The potassium ionophore valinomycin 
served as a positive control in   Fig. 3 E  . 
  The general idea of the interplay between depolarization 
of the mitochondrial membrane and ROS production is that, 
upon mitochondrial damage or dysfunction, mitochondrial pores 
open and allowing the infl  ux of potassium and calcium cations, 
thereby depolarizing the mitochondrial membrane, which in 
turn induces ROS production and release (  Boveris and Chance, 
1973  ). Because the damage of the mitochondrial membrane can 
also be caused by initial doses of ROS triggering ROS-induced 
ROS release (  Zorov et al., 2000  ), it remained unclear if in our 
system the initial trigger is an increase in ROS causing depolar-
ization or vice versa. However, scavenging of intracellular super-
oxide with PEG-catalase upon knockdown of PHB1 did not 
reverse the depolarization of the mitochondrial membrane ( Fig. 3 E , 
bottom right), indicating that the drop in membrane potential 
results in increased ROS production and not vice versa. 
  Mitochondrial ROS are produced by complex I and/or III 
(  Boveris et al., 1976  ;   Takeshige and Minakami, 1979  ) and ROS 
production can be elevated upon inhibition of complex I and/or III 
activity (  Boveris and Chance, 1973  ). Therefore, we investigated 
the relative contribution of complex I and III activity to overall 
mitochondrial respiration by measuring oxygen consumption be-
fore and after inhibition of these complexes with rotenone and anti-
mycin-A, respectively. We found that the contribution of complex I 
activity in PHB1-depleted ECs was 30% lower than in control 
cells (  Fig. 3 F  ), whereas the contribution of complex III activity 
was virtually identical ( Fig. 3 G ). Additionally, the degree of mito-
chondrial coupling was analyzed by measuring oxygen consump-
  Table I.   Cell cycle analysis of PHB1 knockdown cells   
24 h 48 h 72 h
Control RNAi
     G1 29.94   ±   3.50 52.47   ±   3.20 61.99   ±   3.93
     S 48.86   ±   2.36 32.52   ±   2.51 24.74   ±   2.09
     G2 19.32   ±   0.67 11.98   ±   1.29 9.36   ±   1.39
     Sub-G1 1.89   ±   0.49 3.03   ±   0.72 3.90   ±   0.61
PHB RNAi
     G1 38.52   ±   1.16 76.71   ±   2.72 78.48   ±   1.84
     S 41.71   ±   1.73 8.80   ±   1.40 7.35   ±   0.99
     G2 17.24   ±   0.97 7.56   ±   0.74 5.09   ±   0.60
     Sub-G1 2.53   ±   0.40 6.93   ±   0.83 9.08   ±   1.56
ECs were transfected with control or PHB1 RNAi, cells were stained with propidium iodide, and the cell cycle was analyzed via FACS analysis after the indicated 
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(Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb
.200706072/DC1). Similar results were obtained in human ECs 
using different RNAi constructs (unpublished data). 
  Loss of PHB1 provokes an antiangiogenic 
phenotype by inﬂ  uencing the cytoskeletal 
balance in vitro 
  Because a defi  ciency of PHB1 increases ROS production, 
which activates Akt and Rac1, we examined changes in cyto-
skeletal architecture. Rac1 and its downstream partners are 
involved in balancing the dynamics of the actin cytoskeleton, 
which in turn impacts cell motility. As seen in   Fig. 5 A  , in con-
trol RNAi-treated ECs, VEGF induced the formation of F-actin  –
  mediated stress fi  bers as expected (  Soga et al., 2001  ), whereas in 
  Persistent hyperactivation of Akt could be the explanation 
for the observed senescent phenotype. Therefore, we checked the 
long-term activation status of Akt and its downstream target 
Rac1. In PHB1-depleted cells, both Akt and Rac1 were persistently 
hyperactivated throughout a time range of 120 min upon VEGF 
stimulation (  Fig. 4 D and E  ). 
  Akt may lie downstream of Rac1 (  Gonzalez et al., 2006  ) 
but this was not the case in our experimental system because a 
Rac1 inhibitor had no impact on Akt S473 phosphorylation in 
PHB1 knockdown cells (  Fig. 4 F  ) but did block VEGF-stimulated 
Rac activation. PHB1 has recently been described to regulate 
the Ras  –  Raf  –  Erk pathways in epithelial cells (  Rajalingam et al., 
2005  ). However, we could not detect any differences in c-Raf 
or Erk-1/2 phosphorylation upon knockdown of PHB1 in ECs 
  Figure 3.       PHB1 regulates mitochondrial function.   (A) ROS production was analyzed by FACS using the dye CM-H  2  -DCFDH. Control RNAi cells are de-
picted in gray, PHB1 RNAi cells are depicted in red, and PHB1 RNAi cells preincubated with PEG-catalase are depicted in green. Positive control cells were 
preincubated with H  2  O  2   (blue). (B) Respirating mitochondria were stained with reduced MitoTracker CM-H  2   XRos (red) in BAECs (top) and rho 
0   ECs (bottom) 
and immunoﬂ  uorescence analyses were performed (blue, DAPI). Bars, 10   μ  m. (C) ROS production of rho 
0   ECs transfected with control (red) or PHB1 siRNA 
(blue) was analyzed by FACS using CM-H  2  -DCFDH. (D) Control (top) and PHB1-depleted BAECs (bottom) were stained with the radiometric dye JC-1 to moni-
tor depolarization of the mitochondrial membrane and intensity of red (left) and green (right) ﬂ  uorescence was analyzed by indirect immunoﬂ  uorescence. 
Bar, 10     m. (E) Control cells (top left) and PHB1 knockdown cells pretreated with (bottom right) or without (bottom left) PEG-catalase were stained with JC-1 
and both FL-1 and FL-2 ﬂ  uorescence was analyzed by FACS. Valinomycin-treated cells served as a positive control for depolarization of the mitochondrial 
membrane (top right). As a mathematical indicator for mitochondrial membrane depolarization, the ratio of means between red and green ﬂ  uorescence was 
calculated. (F and G) Complex I and III activity of PHB1-depleted cells was calculated and normalized to control cells by measuring oxygen consumption in 
the presence and absence of rotenone, antimycin-A, and azide. Error bars show the calculated standard deviation.   n   = 3; *, P   <   0.05.     JCB • VOLUME 180 • NUMBER 1 • 2008  106
completely blunted in cells lacking PHB1 (  Fig. 5 D  ). Both migra-
tion and tube formation experiments were performed at early 
time points (5 h for both migration and tube formation) to 
 obviate the antiproliferative phenotype of the PHB knockdown. 
Thus, upon loss of PHB1, increased ROS production leads 
to increased Akt and Rac1 activity that, via cytoskeletal re-
arrangements, blunts the angiogenic capacity of ECs in vitro. 
Experiments in   Fig. 5 (C and D  ) were also performed in EA.
hy926 cells using different RNAi constructs and showed similar 
results (not depicted). 
  PHB1 knockdown reduces blood vessel 
formation in vivo 
  Next, we wanted to examine if the antiangiogenic phenotype 
in vitro was also applicable in vivo. Because knockout animals for 
PHB1 were not available, we performed siRNA-based matrigel 
angiogenesis assays in vivo. This method has been shown to 
PHB1 knockdown cells, VEGF-induced stress fi  ber formation 
was attenuated and demonstrated a higher abundance of cortical 
actin at the periphery of the cells. This impairment in VEGF-
induced stress fi  ber formation was rescued by preincubation 
of cells with PEG-catalase and was therefore ROS dependent 
(  Fig. 5 A  ). Furthermore, the observed change in senescent cell 
morphology upon PHB1 knockdown (  Fig. 2 B  ) could be res-
cued by scavenging H  2 O 2   with PEG-catalase in live cell imaging 
experiments (  Fig. 5 B  ) comparing PHB1 knockdown cells 
before (left) and after (right) addition of PEG-catalase for 
30 min. Because dynamic changes in the cytoskeleton control 
cell motility, which is highly important for the motile pheno-
type of ECs, we examined VEGF-stimulated migration and 
3D tube formation. Knockdown of PHB1 caused a decrease 
in VEGF-stimulated directional cell migration that was also 
rescued by scavenging H  2 O 2   with PEG-catalase (  Fig. 5 C  ). 
Furthermore, VEGF-induced 3D tube formation was almost 
  Figure 4.       PHB1 regulates Akt and Rac1 activity.   (A) The level of phosphorylated (P473) and total Akt (after 100-ng/ml VEGF stimulation for different time 
points) was examined via Western blotting after PHB1 knockdown in ECs (middle) in comparison to control cells (left) and PHB1 knockdown cells prein-
cubated with PEG-catalase (right). (B) H  2  O  2   activates Akt phosphorylation, as shown by Western blotting. (C) Rac1 activity assays were performed using 
control and PHB1 knockdown cells, and active Rac1 pulldowns as well as total cell lysates were Western blotted against Rac1 and PHB1. Cells were treated 
with 100 ng/ml VEGF and/or PI3-K inhibitors wortmannin (50 nM) and LY294002 (30     M) as indicated. (D) Phospho-Akt (P473) and active Rac1 were 
monitored in control and PHB1 knockdown cells upon 100-ng/ml VEGF stimulation for the indicated time points. (E) Quantiﬁ  cation of Akt phosphorylation 
(top) and active Rac1 (bottom) normalized to total Akt and Rac, respectively, from three independent experiments. *, P   <   0.05. (F) Rac1 activity in ECs 
pretreated with VEGF and/or a Rac1 inhibitor as indicated by Western blot analysis of total cell lysates for p-Akt, total Rac1, PHB1, and active Rac1. Error 
bars show the calculated standard deviation.     107 PROHIBITIN CONTROLS SENESCENCE AND ANGIOGENESIS   •   SCHLEICHER ET AL.
  Discussion 
  The data provided herein is the fi  rst characterization of PHB1 in 
the vascular system and provides an interesting connection 
between mitochondrial function, senescence, and vascular 
homeostasis. We show that PHB1 is expressed in ECs and that the 
loss of PHB1 results in a block in electron transport at complex I, 
increased mitochondrial ROS generation, and cellular senescence 
that culminates in the loss of several endothelial functions includ-
ing cell migration, cell proliferation, and blood vessel formation. 
These results stand in contrast to the putative nuclear roles of 
PHB1 as a tumor suppressor gene and regulator of transcription 
(  Wang et al., 2002b  ;   Fusaro et al., 2003  ;   Rastogi et al., 2006a  ) 
and suggests that the main function of PHB1 in primary mam-
malian cells is to regulate mitochondrial integrity. 
  PHB1 is a highly conserved and broadly expressed protein 
defi  ning the heterologous protein family of prohibitins. PHB1 
has been shown to be localized to different cell compartments 
including mitochondria and the nucleus as well as lipid rafts in 
successfully knock down sphingosine-1-phosphate expression 
in vivo (  Chae et al., 2004  ). To reduce immune driven angio-
genesis, growth factor  –  reduced matrigel and immunodefi  cient 
severe combined immunodefi  ciency mice were used. The matrigel 
was mixed with basic FGF, VEGF, and RNAi constructs and 
injected subcutaneously. 12 d after injection, gels were harvested, 
fi  xed, and paraffi  n embedded for histochemical analysis. Immuno-
staining for PHB1 in the gel showed successful knockdown 
of PHB1 in cells invading the gel compared with the control 
(  Fig. 6 A  ). Interestingly, total cell counting revealed less overall 
cellular invasion into the PHB1 knockdown gels compared with 
control (  Fig. 6 B  ). To quantify the number of ECs invading the 
gel, sections were stained for the EC marker PECAM-1. EC in-
vasion was inhibited to a greater extent than overall cell inva-
sion (  Fig. 6 C  ), which could be an effect of reduced motility of 
ECs with reduced PHB1 expression. Furthermore, the reduced 
number of PECAM-1 – positive cells was corroborated by a marked 
reduction in red blood cell  –  positive structures in the PHB1 knock-
down gels (  Fig. 6 D  ). 
  Figure 5.       Loss of PHB provokes an antiangiogenic phenotype by inﬂ  uencing the cytoskeletal balance in vitro.   (A) Actin stress ﬁ  ber formation (stained 
with phalloidin) was examined via indirect immunoﬂ  uorescence analysis using control (upper left) and PHB1 knockdown (top right and bottom) cells 
stimulated with VEGF (all) and PEG-catalase (bottom) and stained with rhodamin-phalloidin (yellow) and DAPI (blue). Bars, 10     m. (B) EC morphology 
after knockdown of PHB1 (left) and incubation with PEG-catalase (right) using life imaging phase contrast microscopy. Insets show a higher magniﬁ  cation. 
Bars, 100     m. (C) Migration of control and PHB1 knockdown cells pretreated with and without PEG-catalase was examined via migration assay in 
the presence and absence of VEGF.   n   = 4; *, P   <   0.05. (D) Tube formation assays on matrigel plugs were performed and quantiﬁ  ed using control and 
PHB1 knockdown cells. Representative examples of tubes are shown on the right. Error bars show the calculated standard deviation.   n   = 3; *, P   <   0.05. 
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vascular system ( Miyauchi et al., 2004 ;  Madamanchi and Runge, 
2007  ). Also, the idea that ROS modulates the actin cytoskeleton, 
thereby inducing senescence, is a well-accepted concept (  Gourlay 
and Ayscough, 2005  ). Additionally, expression of PHB1 itself 
has been shown to prevent senescence in both plants and yeast 
(  Piper et al., 2002  ;   Chen et al., 2005  ). Hyperactivation of other 
mitogenic pathways as a trigger of senescence could be excluded 
because we were not able to observe changes in p38 MAPK (un-
published data) or c-Raf and Erk1/2 phosphorylation after PHB1 
knockdown, although PHB1 has been previously shown to infl  u-
ence Ras/c-Raf signaling in epithelial cells (  Rajalingam et al., 
2005  ). The loss of the nuclear functions of PHB1, e.g., inter-
action with E2F and p53 transcription factors, as a further trigger 
of senescence is possible but not likely in primary ECs because 
these interactions would result in increased cell growth in the 
absence of PHB1 as is observed in cancer cells (  Wang et al., 
2002b  ;   Fusaro et al., 2003  ). 
 Downstream of Akt, the activity of the small GTPase Rac1 
plays an important role in regulating cytoskeletal dynamics 
(  Burridge and Wennerberg, 2004  ). The signaling pathways 
downstream of Rac1 are complex because various pathways are 
affected, dependent on cell system, stimulus, and the duration 
of the stimulus. Two common and accepted pathways through 
which Rac1 infl  uences actin polymerization are via p21-activated 
kinase (PAK) through LIM-kinase to cofi  lin and via PAK through 
myosin heavy chain and light chain kinases (  Edwards et al., 
1999  ;   Kiosses et al., 1999  ;   Sells et al., 1999  ;   van Leeuwen et al., 
1999  ). Because Rac1 activity assays were determined using the 
PAK-binding domain for active Rac1, it is very likely that 
the observed hyperactivation of Rac1 signals through either of 
the described pathways to the actin cytoskeleton. In fact, a 
dramatic change in actin stress fi  ber formation in ECs occurred 
upon PHB1 knockdown, which could be rescued by scavenging 
ROS with PEG-catalase. Most importantly, these observations 
are reliable functional assays that are known to be dependent 
on cytoskeletal dynamics and properly balanced Rac1 activity 
(  Fukata et al., 2003  ) because both migration and tube formation 
were clearly reduced in ECs lacking PHB1. These observations 
cannot be explained by reduced proliferation because each 
assay was designed to last 5 h or less. Furthermore, reduced 
migration could be rescued by scavenging H  2 O 2  , supporting the 
concept that ROS- and Akt-mediated senescence leads to cyto-
skeletal rearrangements and decreased cell mobility. 
  Because angiogenesis is a multistep process involving 
cell proliferation, migration, and morphogenesis, we examined 
the in vivo function of PHB1 using RNAi constructs injected 
subcutaneously into mice and monitored cell invasion and 
blood vessel formation (  Fig. 6  ). This approach has been suc-
cessful in showing the proangiogenic actions of sphingosine-1-
phosphate in vivo (  Chae et al., 2004  ) and is a relatively easy 
approach when knockout mice are nonviable or not available. 
RNAi-mediated knockdown of PHB1 reduced overall cellular 
infi   ltration and specifi   cally reduced EC-positive structures, 
demonstrating that PHB1 function is required for normal angio-
genesis in vivo. 
 In summary, PHB1 expression in ECs is mandatory for main-
taining both mitochondrial and vascular function by regulating 
the plasma membrane (  Morrow and Parton, 2005  ). We show that 
PHB1 is expressed in both ECs and SMCs in the murine aorta 
as well as in a variety of primary ECs in vitro. Our colocalization 
experiments show that PHB1 is primarily localized in the mito-
chondria of ECs (  Fig. 1  ) despite evidence supporting its local-
ization in the nucleus (  Fig. 1  ) and in lipid rafts (not depicted). 
To examine the function of PHB1 in the vascular system, we 
chose a loss-of-function strategy in primary ECs using RNAi 
because overexpression and knockdown studies in cancer cell 
lines have suggested its role as a tumor suppressor (  Wang et al., 
2002b  ;   Fusaro et al., 2003  ;   Rastogi et al., 2006a  ), vertebrate 
knockout models were not available, and the knockout of the 
PHB1 homologue in   Drosophila    melanogaster   revealed a lethal 
phenotype (  Eveleth and Marsh, 1986  ). 
  The knockdown of PHB1 induced a cellular senescent 
phenotype characterized by a change in morphology, cell cycle 
block, decreased proliferation, increased expression of the 
cell cycle inhibitors p16 and p21, and senescence-associated 
    -galcatosidase expression. This is in contrast to a recent study 
documenting that RNAi knockdown of PHB1 in the breast carci-
noma cell line MCF-7 prevents cellular senescence and increases 
cell growth (  Rastogi et al., 2006a  ). Perhaps PHB1 exerts a dif-
ferent function in primary cells (i.e., ECs) versus cancer cells 
with multiple genetic mutations in known oncogenic pathways. 
Senescence usually occurs by telomere shortening but can also 
be telomere independent, thus maintaining cells in a quiescent 
state of low metabolism. Telomere-independent cellular senes-
cence is believed to be triggered by stress factors such as DNA-
damaging agents, radiation, oxidative stress, retinoids, oncogenes, 
or hypermitogenic stimuli such as overexpression of Raf (  Sewing 
et al., 1997  ) or constitutive active Akt (  Miyauchi et al., 2004  ). 
In the case of decreased PHB1 expression, an alteration of mito-
chondrial function resulted in increased O 
2      production.  Increased 
mitochondrial ROS production was induced by depolarization 
of the mitochondrial membrane and a block of electron fl  ow 
at complex I, which together with complex III is the accepted 
source of mitochondrial ROS (  Boveris et al., 1976  ;   Takeshige 
and Minakami, 1979  ). Because the contribution of complex III 
activity and the degree of mitochondrial coupling was   similar 
in PHB1 knockdown cells, we hypothesize that a   substantial 
amount of the electrons within the inhibited complex I are used 
for superoxide production when PHB levels are reduced. However, 
we propose that, under these circumstances, there are compen-
satory mechanisms at play that maintain cytochrome oxidase 
(complex IV) activity and overall ATP production. Such mecha-
nisms likely involve an increase in electron fl  ow via complex II 
and/or III. Other sources of ROS, e.g., NADPH oxidase, NO syn-
thase, or xanthine oxidase, could be ruled out because BAECs 
depleted of respiring mitochondria (rho  °   ECs) did not demon-
strate ROS production after knockdown of PHB1. 
  Increased ROS production resulted in subsequent hyper-
activation of Akt, triggering the senescent phenotype. Accordingly, 
ROS production, cellular morphology, hyperactivated Akt, stress 
fi  ber formation, and the loss of migrative capacity could all 
be rescued by preincubation of cells with the ROS scavenger 
PEG-catalase. Indeed, elevated ROS as well as overexpression 
of constitutively active Akt are able to promote senescence in the 109 PROHIBITIN CONTROLS SENESCENCE AND ANGIOGENESIS   •   SCHLEICHER ET AL.
  siRNA contructs 
  Nonmodiﬁ   ed and high performance puriﬁ   ed siRNA duplexes were ob-
tained from QIAGEN. The constructs were directed against the following 
sequences: 5    -AATGTGGATGCTGGGCACAGA-3     for knocking down PHB1 
in BAECs and the in vivo angiogenesis assay and 5    -AAAGGCTGAGCAA-
CAGAAAAA-3     for knocking down PHB1 in HUVECs and EA.hy926. 
A negative control (QIAGEN) and a scrambled sequence of the ﬁ  rst con-
struct 5    -AAGAGTGTCGGATGCAGGATC-3     were used as controls. 
  Cell culture and transfection with RNAi constructs 
  BAECs and HUVECs were isolated from freshly harvested aorta or um-
bilical cords, respectively, and cultured and characterized as described 
previously (  Bernatchez et al., 2001  ). BAECs and HUVECs were not pas-
saged for more than eight and ﬁ  ve passages, respectively. For knock-
down of PHB1, ECs were transfected with 25 nM of the corresponding 
RNAi constructs using Oligofectamine (Invitrogen) according to the 
manufacturer  ’  s instructions. The cells were maintained in OptiMem (Invitro-
gen) for 8 h and then incubated in full medium for a total of 48 h if not 
stated otherwise. 
  Generation of rho 
0   ECs 
  Rho 
0   ECs were generated by depleting BAECs of respiring mitochondria. 
Therefore, BAECs were incubated in full medium also containing 250 ng/ml 
ethidium bromide, 50     g/ml uridine, and 1 mM pyruvate for 2 wk. The 
medium was changed every other day. 
  Western blotting 
  Protein samples were dissolved in sample buffer (200 mM Tris-HCl, pH 
6.8, 6% SDS, 20% glycerol, 10% DTT, and 0.1 mg/ml bromophenol blue), 
separated by SDS-PAGE, and transferred to nitrocellulose membranes. The 
membranes were blocked in TBS containing 0.1% casein or 5% BSA. De-
tection was performed with primary antibodies as indicated in combina-
tion with Alexa Fluor 680 (Invitrogen) –   or IRDye 800 (Rockland) –  conjugated 
ROS production and cellular senescence. These fi  ndings under-
score the emerging concept of mitochondria as an important 
signaling organelle and ROS as important signaling molecules 
in vascular biology (  Quintero et al., 2006  ;   Madamanchi and 
Runge, 2007 ). Because both senescence as well as mitochondrial 
function have been linked to pathological events in the vascular 
system such as atherosclerosis (  Madamanchi and Runge, 2007  ), 
PHB1 could become an interesting candidate for further studies 
in this fi  eld. 
  Materials and methods 
  Materials 
  JC-1, CM-H  2  -DCFDA, valinomycin, rhodamine-phalloidin, rotenone, anti-
mycin-A, and both reduced and nonreduced MitoTracker were obtained 
from Invitrogen. Growth factor  –  reduced matrigel was obtained from BD 
Biosciences and PEG-catalase, ethidium bromide, and uridine were ob-
tained from Sigma-Aldrich. Human VEGF165 was a gift of Genentech. 
Antibodies against Akt, phospho-Akt, and the senescence     -galactosidase 
staining kit were obtained from Cell Signaling Technology. Antibodies 
against PECAM-1 (clone M-20), p16 (clone C-20), and p21 (clone C-19) 
were obtained from Santa Cruz Biotechnology, Inc. The Rac1 antibody 
was obtained from BD Biosciences. Antibodies against     -actin and PHB1 
were obtained from Sigma-Aldrich and Thermo Fisher Scientiﬁ  c, respec-
tively. The antibody against phospho-eNOS was obtained from Invitrogen 
and antibodies against eNOS and c-Raf were obtained from BD Biosci-
ences. phospho-c-Raf (clone 56A6), Erk1/2, phosphor-Erk1/2 (clone E10) 
antibodies were obtained from Cell Signaling Technology. The Amplex red 
hydrogen peroxide kit was obtained from Invitrogen. 
  Figure 6.       Loss of PHB reduces angiogenesis in vivo.   Matrigel angiogenesis assays in vivo were performed using gels mixed with control or PHB1 knock-
down constructs. Gels were dissected, sectioned, and analyzed immunohistochemically (  n   = 5). (A) Both control and PHB1 knockdown gel slides were 
stained for PHB1 to show successful knockdown and images were taken using a 20  ×   objective. Bars, 10     m. (B) After hematoxylin and eosin staining, 
images were taken using a 4     objective to quantify total cells invading the gels. Representative images of control and a PHB1 knockdown gel are shown 
on the bottom.   n   = 5; *, P   <   0.05. Bars, 100     m. (C) Angiogenic ECs in both control and PHB1 knockdown gels were quantiﬁ  ed by staining the slides for 
PECAM-1 after taking images with a 10     objective. An example of PECAM-1  –  positive structures (arrows) in a control gel is shown on the right.   n   = 5; 
*, P   <   0.05. Bar, 50     m. (D) Red blood cell  –  positive vascular structures (indicated by arrows in the representative example from a control gel shown on the 
right) were quantiﬁ  ed in both control and PHB1 knockdown gels after staining with hematoxylin and eosin and taking images with a 10  ×   objective. Error 
bars show the calculated standard deviation.   n   = 5; *, P   <   0.05. Bar, 50     m.     JCB • VOLUME 180 • NUMBER 1 • 2008  110
catalase for 2 h. Living cells were gated according to propidium iodide 
staining and FL-1 and FL-2 ﬂ  uorescence was measured using a FACScalibur 
cell analyzer and CellQuest software (Beckton Dickinson). Data were analyzed 
using WinMDI software (provided by J. Trotter, Scripps Research Institute, 
La Jolla, CA). 
  Measurement of H  2  O  2   in cell lysates 
  ECs transfected with control or PHB1 knockdown constructs on a 10-cm 
dish were scraped in 200-    l assay buffer and frozen/thawed in liquid 
nitrogen three times. 50     l of the supernatants were used to measure H  2  O  2   
concentrations by ﬂ  uorometric analysis with the Amplex red kit according 
to the manufacturer  ’  s protocol on a 96-well scale. 
  Measurement of mitochondrial complex activity 
  siRNA transfected, exponentially growing BAECs were trypsinized and re-
suspended in full medium (10 
6   cells/ml). 5 ml of cell suspension was used 
for measuring oxygen consumption with an oxygen probe in the absence 
and presence of inhibitors for complex I (10     M rotenone), complex III 
(10     M antimycin-A), or mitochondrial respiration (0.05% azide). Complex I 
and III activities were calculated with the following formula: activity = 
1      [(Slope  inhibitor     cons        Slope  azide     cons  )/(Slope  total     cons        Slope  azide     cons  )]. 
Afterward, complex activities of PHB1 knockdown cells were normalized 
to control cells. 
  Measurement of mitochondrial coupling 
  siRNA transfected, exponentially growing BAECs were trypsinized and re-
suspended in full medium (10 
6   cells/ml). 5 ml of cell suspension was used 
for measuring oxygen consumption with an oxygen probe in the absence 
and presence of an uncoupler (0.5   μ  g/ml oligomycine) or an inhibitor of 
mitochondrial respiration (0.05% azide). 
  The degree of coupling was calculated with the following formula: 
coupling = 1      [(Slope  uncoupler     cons        Slope  azide     cons  )/(Slope  total     cons        
Slope  azide     cons  )]. Afterward, the degree of coupling of PHB1 knockdown 
cells was normalized to control cells. 
  Tube formation assay 
  3      10 
4   cells previously transfected with RNAi constructs and cultured for 
48 h were trypsinized, washed, and seeded on top of growth factor  – 
reduced matrigel plugs in DME containing 0.2% FCS with or without 
100 ng/ml VEGF. Images of formed tubes were taken using a 5     phase 
contrast objective mounted on an Axiovert 200 microscope at room tem-
perature after 5 h and tube lengths were measured using OpenLab software. 
Only closed tubes were taken into the measurement. 
  Cell migration assay 
  Cell migration was evaluated using a microchamber (Boyden). Near-
  conﬂ  uent BAECs were washed with DME, trypsinized, and resuspended in 
DME/0.2% FCS, and then 4   ×   10 
4   cells in 50     l were seeded in the upper 
chamber and the lower chamber was ﬁ  lled with DME containing 0.2% FCS 
with or without 100 ng/ml VEGF and separated by an 8-    m gelatin-coated 
polycarbonate ﬁ  lter. 5 h after incubation at 37  °  C, the nonmigrated cells 
were scraped with a plastic policeman and the migrated cells were stained 
using Quick-Diff (Shandon, Inc.) solutions and counted. 
  Matrigel angiogenesis assay in vivo 
  The assay was performed as described previously (  Chae et al., 2004  ) with 
minor modiﬁ  cations. In brief, female severe combined immunodeﬁ  ciency 
mice were injected with 0.5 ml of growth factor  –  reduced Matrigel premixed 
with 150 ng/ml VEGF, 50 ng/ml FGF, and 2     M of the siRNA constructs. 
After 10 d, matrigel plugs were harvested, ﬁ  xed in 4% paraformaldehyde, 
and embedded in parafﬁ  n. Sections were stained with hematoxylin and 
eosin, anti-PECAM-1, or anti-PHB1. 
  NO release experiments 
  BAECs were grown to conﬂ   uence in 6-well tissue culture plates (Becton 
Dickinson). The medium was removed and serum-free DME containing vari-
ous concentrations of peptides or vehicle (0.1% DMSO) was added and 
incubated for 6 h. After pretreatment, the medium was removed and cells 
were stimulated with DME containing peptides and/or VEGF for 30 min. 
After a 30-min incubation, the medium was collected and cells were tryp-
sinized and counted with a Coulter counter. NO release from conﬂ  uent 
BAECs was assessed in the medium by measuring nitrite levels using a 
NO-speciﬁ  c chemiluminescence analyzer. Data are reported as picomole 
of nitrite per 10 
6   cells. 
antibodies to rabbit or mouse IgG, respectively, and the Odyssey detection 
system (Li-Cor). 
  Quantiﬁ  cation of Western blots 
  Western blot bands of phosphorylated Akt and active Rac1 were quanti-
ﬁ  ed and normalized against total Akt and Rac1, respectively, using ImageJ 
software. For calculating relative intensities, Western blots from three 
  in  dependent experiments were quantiﬁ  ed and averaged. 
  Rac1 activity assays 
  Rac1 activity was analyzed using the Rac1 assay kit (Millipore) according 
to the manufacturer  ’  s instructions. Conﬂ  uent BAECs were starved for 6  –  8 h. 
After stimulation with 100 ng/ml VEGF for 15 min, cells were lysed, insol-
uble material was spun down, and protein concentration was assessed. 
500     g of total protein per sample was used to pull down active Rac1. 
Both active Rac1 and total cell lysates were analyzed for Rac1 by Western 
blotting using the Rac1 antibody (BD Biosciences). 
  Indirect immunoﬂ  uorescence and live imaging 
  For indirect immunoﬂ   uorescence, cells were seeded on coverslips ﬁ  xed 
with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and 
blocked with PBS containing 0.1% Tween 20 (PBST), 5% BSA, and 5% 
serum. Afterward, cells were incubated with primary antibodies followed by 
incubation with Alexa Fluor 488  –   or 568  –  coupled secondary antibodies 
(Invitrogen) and 1     g/ml DAPI. For staining of F-actin stress ﬁ  bers, cells 
were incubated with rhodamine-phalloidin. Pictures were taken using a 
63     oil immersion objective (Carl Zeiss, Inc.) at room temperature unless 
stated otherwise. For live imaging, pictures were taken using a 20     phase 
contrast objective (Carl Zeiss, Inc.) together with a 37  °  C incubation cham-
ber. Images were acquired using a microscope (Axiovert 200; Carl Zeiss, 
Inc.) in combination with OpenLab software (Improvision). 
  Immunohistochemistry 
  Specimens were ﬁ  xed in 4% paraformaldehyde, permeabilized with 0.2% 
Triton X-100, embedded in parafﬁ  n, and sectioned (5     m). Upon antigen 
retrieval with 20 mM sodium citrate, pH 6, and incubation with a primary 
antibody, sections were stained using biotin-coupled secondary antibodies 
(Jackson ImmunoResearch Laboratories) together with the Vectastain ABC 
kit (Vector Laboratories) and Nova red (Vector Laboratories) as a substrate. 
Pictures were taken and acquired using 4, 10, or 20     objectives with 
a microscope (Axioskop2 plus; Carl Zeiss, Inc.) in combination with a 
camera (AxioCam MRc) and MRGrab software (both from Carl Zeiss, Inc.) 
at room temperature. 
         -Galactosidase assay for senescent cells 
  BAECs were seeded on glass coverslips and transfected with siRNA con-
structs, and the expression of     -galactosidase was monitored using the 
senescence     -galactosidase staining kit (Cell Signaling Technology) according 
to the manufacturer  ’  s instructions. Pictures were taken with a 10     phase 
contrast objective (Carl Zeiss, Inc.) on a microscope (Eclipse 80i) with a 
camera (DXM 1200C; both from Nikon) at room temperature using NIS-
Elements D software (Nikon). 
  Cell cycle analysis 
  Cell cycle of control and PHB1 knockdown transfected cells via propidium 
iodide staining and FACS analysis was performed as described previously 
(  Schleicher et al., 2005  ). 
  Proliferation assay 
  10 
4   cells were seeded on 24-well dishes, transfected with RNAi constructs 
upon attachment, and cultured in full medium. Cells were trypsinized, re-
suspended, and counted at indicated time points using a Coulter counter 
(Z-1; Beckman Coulter). 
  FACS analysis of mitochondrial membrane potential and ROS production 
  Cells were trypsinized, washed, and resuspended in full medium. For anal-
ysis of the mitochondrial membrane potential, resuspended cells were in-
cubated with 1     g/ml JC-1 for 10 min and 5     g/ml propidium iodide for 
30 min at 37  °  C. As a positive control, transfected cells were preincubated 
with 50     M valinomycin for 2 h. For analysis of ROS production, cells 
were starved for 2 h in DME containing 0.2% FCS and resuspended cells 
were incubated with 5     M CM-H  2  -DCDA and 5     g/ml propidium iodide 
for 30 min at 37  °  C. As a positive control, cells were preincubated with 
100     M H  2  O  2   for 20 min. To ensure that DCDA was detecting H  2  O  2  , 
PHB1 knockdown transfected cells were preincubated with 10     g/ml PEG-111 PROHIBITIN CONTROLS SENESCENCE AND ANGIOGENESIS   •   SCHLEICHER ET AL.
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